FDA post-market role criticized
185982
The editors of the Journal of the American Medical Association (JAMA) are calling for an end to the US Food and Drug Administration&#39;s (FDA) role in post-market monitoring of the safety of drugs it approves.
158802
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process.
463381
A U.S. Food and Drug Administration  reviewer who criticized the agency's handling of Merck & Co.  Inc.'s now-withdrawn Vioxx painkiller may be forced to another  position at the agency, a lawyer for the scientist said on  Monday.
463025
A Food and Drug Administration reviewer who has criticized the agency for being lax in monitoring drug safety said on Thursday five medicines on the market need close scrutiny for possible side effects.
203692
By Katherine Griffiths in New York and Stephen Foley in London. The United States&#39; Food and Drug Administration used to be a regulator so trusted that when it waved through the introduction of genetically modified
75445
The United States needs a better system to detect harmful effects of drugs already on the market, and it should be independent of the Food and Drug Administration and the drug industry, medical
8561
A government program designed to build a national stockpile of biodefense drugs after the 2001 anthrax attacks has a bad reputation among drug companies. Pharmas and the feds trade blame.
161932
The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.
30972
A US Food and Drug Administration reviewer who has accused the agency of being lax in monitoring drug safety on Thursday said five medicines on the market need closer scrutiny.
693961
WASHINGTON Nov 5, 2004 - Buffeted by criticism, the Food and Drug Administration said Friday that it would appoint a director of drug safety and take other steps to improve the safety of medications.
231875
The US Food and Drug Administration (news - web sites) on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck &amp; Co.
2756
NEW YORK - The pharmaceutical industry has endured a disastrous 2004, and the aftermath will linger into the new year. Regulators at the Food and Drug Administration were expected to take a more cautious approach
378783
The Food and Drug Administration lacks clear regulatory authority and is chronically underfunded, shortcomings hindering its ability to evaluate the safety of drugs used by millions of Americans, according to outside scientists the agency asked to critique its performance.
54539
WASHINGTON - The US pharmaceutical industry that exports billions of dollars worth of medicine around the world faced new scrutiny Friday after a survey revealed nearly one-fifth of its government overseers had experienced pressure to approve drugs they
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
737440
An unsurprising response from the FDA.
51383
Nov. 18, 2004 - An FDA scientist says the FDA, which is charged with protecting America&#39;s prescription drug supply, is incapable of doing so.